SAAHA is controlled by an Executive Council consisting of nominated individuals from all ordinary member companies. The President of SAAHA is Alan Kloeck (MSD Animal Health) and the Vice President is Glynn Catton (Stride Distributors). SAAHA is a member of the HealthForAnimals, a non-profit, non-governmental organization representing companies and industry associations from both developed and developing countries.
We serve the farmer and other end-users of veterinary products by:
Ensuring that only quality products that are registered and fit for use are sold and distributed;
Facilitating new and/or improved products are regularly put on the market through research and development internationally and locally;
Looking after the interests of emerging farmers;
Conducting research into vector resistance in South Africa;
Ensuring that sales personnel are properly trained and accredited.
To promote and support an economically viable and innovation driven animal health industry, contributing to a healthy, secure and safe food supply through a high level of health and welfare of all animals and the environment.
To act as the unified voice in liaison with stakeholders which have an impact on the animal health industry;
To encourage and assist the development of predictable science-based regulatory processes and standards;
To provide unique and quality service to our members;
To promote and maintain adherence to a high level of ethics.
All SAAHA members sign an agreement to comply with and to be bound by the SAAHA Code of Conduct. This code sets out the Industry and Trade standards for research, development, manufacturing, production, marketing, handling, warehousing and distribution including importation and/or exportation of animal health products as defined.
The SA Code of Marketing Ethics for Veterinary Pharmaceuticals aims at promoting and applying marketing practices that are accurate, unambiguous, factual and fair. Furthermore, the objective of this code is to ensure that the marketing of veterinary pharmaceuticals to veterinary and allied professionals and the general public is carried out in a responsible, ethical and professional manner, based on practical and scientifically validated information. It also aims to ensure that marketing activities encourage the rational use of veterinary medicines by veterinary and allied professionals and the general public.
○ Amendments (New working group)
○ Autogenous vaccines (Active)
○ Clinical trials (New working group)
○ Compounding (Not presently active)
○ Complementary medicines (Not presently active)
○ Devices (Active)
○ Electronic dossiers (Not presently active)
○ General guideline (Not presently active)
○ GMP (Active)
○ Labelling (Not presently active)
○ Marketing code (Active, requires input of member marketing personnel)
○ Mutual recognition and abbreviated review procedure (Not presently active)
○ One Act (Not presently active)
○ Pharmaceutical and analytical (Not presently active)
○ Pharmacovigilance (New working group)
○ Phase-out of inert ingredients of toxicological concern (Not presently active)
○ Post-importation testing (Active)
○ Salary Survey (Active)
○ Sales Statistics (Active)
○ Social media (New working group)
○ Stability (Not presently active)
○ Stock Remedy Regulations (New working group being formulated)
○ Training and accreditation (Active, requires input of member marketing personnel)
○ Training – Exco focus group (Active)
○ Vaccines (Active)